image credit: Vecteezy

Congress has a ‘time-limited window’ to shake up drug pricing, employers, health groups say

July 14, 2021


A chance for meaningful drug pricing reform is upon us, dozens of purchasers, healthcare and employer groups contend. But Congress needs to capitalize on its “time-limited” opportunity, or the problem could stagnate or worsen.

In a letter to a bipartisan group of lawmakers, groups comprised of Families USA, Lower Drug Prices Now, Patients for Affordable Drugs and more called on Congress to empower Medicare and the Department of Health and Human Services (HHS) to negotiate drug prices, install price-hike limits and redesign Medicare Part D to slash costs for beneficiaries and taxpayers.

Read More on FiercePharma